| scholarly article | Q13442814 |
| P2093 | author name string | R. D. Diamond | |
| W. Jao | |||
| B. Epstein | |||
| R. Krzesicki | |||
| P2860 | cites work | Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g | Q26778365 |
| Causes of death in adults with acute leukemia | Q33331234 | ||
| Interaction of Aspergillus fumigatus Spores with Human Leukocytes and Serum | Q34154870 | ||
| Quantitative studies of phagocytosis by polymorphonuclear leukocytes: use of emulsions to measure the initial rate of phagocytosis | Q34494507 | ||
| Leukocytic function in hypogammaglobulinemia | Q35579364 | ||
| Experimental visceral aspergillosis | Q36078707 | ||
| The pathogenesis of experimental pulmonary aspergillosis. An ultrastructural study of alveolar macrophages after phagocytosis of a flavus spores in vivo | Q36101341 | ||
| Evidence for hydroxyl radical production by human neutrophils | Q37046046 | ||
| Interference with normal phagosome-lysosome fusion in macrophages, using ingested yeast cells and suramin | Q39329995 | ||
| Aspergillosis. The spectrum of the disease in 98 patients | Q39990857 | ||
| Rhinocerebral phycomycosis in association with diabetic ketoacidosis. Report of two cases and a review of clinical and experimental experience with amphotericin B therapy | Q40011312 | ||
| Deep fungal infection in systemic lupus erythematosus - three cases reported, literature reviewed | Q40898157 | ||
| Lactoferrin, an iron-binding protein in neutrophilic leukocytes | Q41842598 | ||
| 2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages II. Dissociation of the inhibitory effects of 2-deoxyglucose on phagocytosis and ATP generation | Q42941112 | ||
| Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases | Q46069727 | ||
| Molecular Weight, Single-Chain Structure and Amino Acid Composition of Human Lactoferrin | Q47381715 | ||
| Phycomycosis complicating leukemia and lymphoma | Q48712251 | ||
| Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. | Q53743142 | ||
| The pathogenesis of experimental pulmonary aspergillosis in normal and cortisone-treated rats | Q54616147 | ||
| The Compromised Host and Infection. II. Deep Fungal Infection | Q64977978 | ||
| Experimental aspergillosis in rats infected via intraperitoneal and subcutaneous routes | Q66896626 | ||
| Deep mycotic infection in the hospitalized adult: a study of 123 patients | Q67328115 | ||
| Fungal infections after renal transplantation | Q67490427 | ||
| Iodination by human polymorphonuclear leukocytes: a re-evaluation | Q67550441 | ||
| Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response | Q67561741 | ||
| Aspergillus pneumonia in hematologic malignancy. Improvements in diagnosis and therapy | Q67583040 | ||
| Aspergillosis complicating neoplastic disease | Q68652920 | ||
| Pneumonia in Acute Leukemia | Q69030987 | ||
| Aspergillosis in four renal transplant recipients. Diagnosis and effective treatment with amphotericin B | Q69197167 | ||
| Normal granulocyte infusion therapy for aspergillosis in chronic granulomatous disease | Q69250513 | ||
| Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features | Q69972987 | ||
| Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis | Q70439654 | ||
| Alternate-Day Amphotericin B Therapy in the Treatment of Rhinocerebral Phycomycosis (Mucormycosis) | Q72016223 | ||
| An extension of the 51Cr-release assay for the estimation of mouse cytotoxins | Q72179734 | ||
| Phycomycetous infection (mucormycosis) in cancer patients: a complication of therapy | Q78590309 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspergillosis | Q259626 |
| P304 | page(s) | 313-328 | |
| P577 | publication date | 1978-05-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis | |
| P478 | volume | 91 |
| Q73107808 | A murine model of zygomycosis by Cunninghamella bertholletiae |
| Q36376760 | Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus |
| Q40268621 | Acquired immunity in experimental murine aspergillosis is mediated by macrophages. |
| Q37005496 | Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae |
| Q72345407 | An emerging opportunistic infection in HIV patients: a retrospective analysis of 11 cases of pulmonary aspergillosis |
| Q39734385 | An overview of macrophage-fungal interactions |
| Q34428108 | Animal models of zygomycosis--Absidia, Rhizopus, Rhizomucor, and Cunninghamella |
| Q40795131 | Antifungal susceptibility testing |
| Q29617908 | Aspergillus fumigatus and aspergillosis |
| Q35107002 | Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography. |
| Q39755181 | Catalases of Aspergillus fumigatus |
| Q37081657 | Cerebral mucormycosis in diabetic mice after intrasinus challenge |
| Q86047456 | Cervicofacial tissue infarction in patients with acute invasive fungal sinusitis: prevalence and characteristic MR imaging findings |
| Q70619638 | Chromoblastomycosis. A morphological investigation of the host-parasite interaction |
| Q39518771 | Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus |
| Q36337019 | Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro |
| Q69578699 | Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis: association with deferoxamine |
| Q40006952 | First reported case of Aspergillus granulosus infection in a cardiac transplant patient. |
| Q36340054 | Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. |
| Q33697679 | Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression |
| Q30452877 | History of medical mycology in the united states |
| Q38223670 | Host-parasite interaction in fungal infections |
| Q35568846 | How to treat fungal infections in ICU patients |
| Q36376608 | Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury |
| Q35823358 | In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus |
| Q34534366 | In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism |
| Q72110927 | Increased T cells lacking immunoglobulin Fc receptors and increased spontaneous morphological blast transformation in a patient with phycomycosis |
| Q40449192 | Integrin Cross-Talk Regulates the Human Neutrophil Response to Fungal β-Glucan in the Context of the Extracellular Matrix: A Prominent Role for VLA3 in the Antifungal Response. |
| Q51685248 | Intubation practice on cadavers should stop. |
| Q40440616 | Invasive aspergillosis in systemic lupus erythematosus |
| Q24290929 | Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae |
| Q37100918 | Killing of Aspergillus spores depends on the anatomical source of the macrophage |
| Q37287794 | Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome |
| Q58803073 | Macrophages inhibit Aspergillus fumigatus germination and neutrophil-mediated fungal killing |
| Q73486180 | Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF) |
| Q36335900 | Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro |
| Q40599488 | Mucorales species activation of a serum leukotactic factor. |
| Q33898647 | Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies |
| Q36533683 | Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection. |
| Q37035999 | Neutrophil chemotactic responses induced by fresh and swollen Rhizopus oryzae spores and Aspergillus fumigatus conidia |
| Q37022405 | Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways |
| Q54487442 | Passive immunization in murine mucormycosis. |
| Q92106852 | Pathogenic Fungal Infection in the Lung |
| Q35777368 | Phagocytosis of medically important yeasts by polymorphonuclear leukocytes |
| Q33614894 | Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon |
| Q38038823 | Pulmonary Aspergillus intracavitary colonization (PAIC). |
| Q35433832 | Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. |
| Q40152378 | Review of neutrophil adherence, chemotaxis, phagocytosis and killing |
| Q55043119 | Robust Phagocyte Recruitment Controls the Opportunistic Fungal Pathogen Mucor circinelloides in Innate Granulomas In Vivo. |
| Q45800178 | Role of Soluble Innate Effector Molecules in Pulmonary Defense against Fungal Pathogens |
| Q41056617 | Role of neutrophils in invasive aspergillosis |
| Q37008593 | Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes |
| Q34611574 | Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus |
| Q26774635 | Sphingolipids as Regulators of the Phagocytic Response to Fungal Infections |
| Q38954056 | Systemic zygomycosis |
| Q46983393 | The mucormycete-host interface |
| Q33515265 | TmpL, a transmembrane protein required for intracellular redox homeostasis and virulence in a plant and an animal fungal pathogen |
| Q33769906 | Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus |
| Q24683790 | Virulence factors of medically important fungi |
| Q40376384 | Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. |
| Q37381337 | Virulence of catalase-deficient aspergillus nidulans in p47(phox)-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease |
| Q24514527 | Zygomycetes in human disease |
Search more.